Last reviewed · How we verify
NCT06700252
Effects of Vestibular Rehabilitation in the Treatment of Dizziness and Balance Disturbances After Concussion
NA trial testing Vestibular Rehabilitation in Concussion in 10 participants. Completed in 28 February 2023.
28 February 2023
Quick facts
| Lead sponsor | Beth Marschner |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 10 |
| Start date | 25 August 2022 |
| Primary completion | 28 February 2023 |
| Estimated completion | 28 February 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Vestibular Rehabilitation
- Traditional Protocol
Conditions studied
- Concussion — all drugs for Concussion →
Sponsor
Beth Marschner
Who can join
18 and older, any sex, with Concussion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to study the effects of including vestibular rehabilitation in the treatment of dizziness and balance disturbances in athletes after concussion. The main questions it aims to answer are: * Does inclusion of vestibular rehabilitation treatment have an effect on symptom resolution in those with concussion? * Does inclusion of vestibular rehabilitation treatment have an effect on the rate of recovery and return to play after concussion? Researchers will compare vestibular rehabilitation treatment inclusion in concussion treatment to a traditional concussion treatment approach to see if the rate of symptom resolution and return to play are affected by including vestibular rehabilitation for participants who have experienced a concussion within one week of presenting for the study. Participants will: * Be randomly assigned to either receive vestibular rehabilitation included in their concussion treatment or have traditional concussion treatment without vestibular rehabilitation. * Complete treatment sessions two times per week for up to four weeks * Complete the corresponding home program for the treatment group * Complete baseline symptom testing and repeat the symptom testing at study completion for data comparison. Testing includes: Sport Concussion Assessment Tool (SCAT5) including 1) the athlete's background 2) symptom evaluation 3) cognitive screening 4) neurological screening and 5) delayed recall, a Dynamic Gait Index (DGI) including 1) gait on level surface 2) change in gait speed 3) gait with horizontal head turns 4) gait with vertical head turns 5) gait and pivot turn 6) step over obstacle 7) step around obstacle 8) stairs, and a vestibular evaluation including 1) patient history 2) visual assessment 3) vertebral artery clearance 4) cervical spine clearance 5) inner ear assessment 6) brief balance assessment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06700252
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Vestibular Rehabilitation
Trials testing the same drug.
- NCT06271694 — Activity and Participation in Vestibular Disorders · NA · completed
- NCT06563076 — Effectiveness of Vestibular Electrical Stimulation in Vestibular Rehabilitation · NA · completed
- NCT06004505 — Effect of Vestibular Rehabilitation on Static Posturography Results · NA · completed
- NCT05676307 — Vestibular Rehabilitaion in Bilateral Vestibular Hypofunction · NA · completed
- NCT05122663 — Emergency Department Vestibular Rehabilitation Therapy for Dizziness and Vertigo · completed
Other recruiting trials for Concussion
Currently open trials in the same condition.
- NCT05426967 — rTMS for Military TBI-related Depression · NA · recruiting
- NCT03710109 — Evaluation of an EEG Based Concussion System · recruiting
- NCT03233646 — Retinal Imaging in Neurodegenerative Disease · recruiting
Other Beth Marschner trials
Trials by the same sponsor.
- NCT06613022 — Effects of Instrument Assisted Soft Tissue Mobilization on Healthy Tissue Regarding Range of Motion and Grip Strength · NA · completed
- NCT06610058 — Effects of Instrument Assisted Soft Tissue Mobilization Regarding Range of Motion and Lower Extremity Power · NA · completed
- NCT06612983 — Effects of Instrument Assisted Soft Tissue Mobilization on Healthy Tissue Regarding Range of Motion and Gait · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06700252 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Beth Marschner
- Last refreshed: 21 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06700252.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing